The Cognitive Peptide Stack: SEMAX, Selank, and Dihexa Compared

Cognitive peptides operate on fundamentally different mechanisms. SEMAX enhances focus through BDNF/NGF upregulation. Selank reduces anxiety through enkephalin system modulation. Dihexa promotes neuroregeneration through hepatocyte growth factor activation. Picking the right one depends on what "cognitive improvement" means for your brain.

SEMAX — The Focus Enhancer

SEMAX is a synthetic analogue of ACTH(4-10) — a fragment of adrenocorticotropic hormone — with a C-terminal Pro-Gly-Pro tripeptide extension that dramatically improves metabolic stability. It upregulates BDNF and NGF in the hippocampus and frontal cortex within 20 minutes of intranasal administration.

The evidence base is predominantly Russian: clinical trials in stroke recovery and cognitive impairment, plus preclinical studies in attention and memory. A meta-analysis of Russian trials found SEMAX added to standard care improved neurological recovery after acute stroke — cognitive improvement appeared 4–7 days earlier than controls in one series.

User profile: someone who needs sustained cognitive performance without stimulant side effects. SEMAX doesn't produce the crash, dependency, or tolerance patterns of stimulant-based nootropics. It's not recreational — the effect is subtler, more about sustained capacity than acute stimulation. Dosing: 200–500 mcg intranasal, 1–3× daily.

Selank — The Anxiolytic With No Sedation

Selank is a synthetic analogue of tuftsin (an immunopeptide) with anti-anxiety effects comparable to benzodiazepines — but without sedation, amnesia, tolerance, or withdrawal. The mechanism is dual: positive allosteric modulation of GABA-A receptors (enhancing inhibitory tone) and enkephalinase inhibition (preserving endogenous opioid tone).

Russian clinical trials demonstrated reductions in Hamilton Anxiety Rating Scale scores comparable to classical benzodiazepines in generalized anxiety disorder. The absence of sedation is the clinical differentiator — Selank reduces anxiety without impairing function. This matters for anyone who needs anxiety relief while remaining productive.

AC-Selank-NH2 is the N-acetylated, C-terminal amidated version with extended metabolic half-life — the standard form offered. User profile: someone whose primary cognitive bottleneck is anxiety rather than focus deficit. Selank doesn't make you smarter; it removes the anxiety noise that blocks cognitive function. Dosing: 200–500 mcg intranasal or 100–300 mcg subcutaneous.

Dihexa — The Neuroregenerator

Dihexa is categorically different from SEMAX and Selank. It's a small-molecule angiotensin IV analogue that binds hepatocyte growth factor (HGF) with high affinity and activates the c-Met receptor — a pathway involved in cell proliferation, migration, and tissue repair in the CNS.

The preclinical data is striking but narrow: Dihexa restored cognitive function in animal models of Alzheimer's disease (scopolamine-treated rats) at picomolar concentrations — orders of magnitude more potent than BDNF by weight. It promoted synaptogenesis (new synapse formation) rather than simply preserving existing synapses.

The human evidence gap is large. No clinical trials exist. All data is preclinical. Dihexa crosses the blood-brain barrier efficiently (oral bioavailability is good), but the safety profile in humans is unknown — the c-Met pathway activation raises theoretical cancer concerns similar to other growth-factor-activating compounds. This is the highest-risk, highest-reward cognitive peptide on the catalog.

User profile: someone with neurodegeneration risk or cognitive decline who has exhausted safer options and is working with a clinician. Dihexa is not a first-line nootropic — it's a research compound with a powerful mechanism and minimal human safety data.

Which One Should You Start With?

The decision tree is straightforward:

• Anxiety is the primary issue → Selank. Reduces anxiety without sedation. Safe profile, well-tolerated.
• Focus/productivity is the primary issue → SEMAX. Sustained cognitive capacity without stimulant side effects. Stronger evidence base than Selank.
• Neurodegeneration/cognitive decline is the concern → Dihexa. Most potent mechanism but least human data. Requires clinical supervision.

The Cognitive Stack combines these based on profile — not everyone needs all three. The quiz on Personalized Peptides determines which cognitive peptides match your goal profile before you invest in a protocol.

For full product pages: SEMAX, Selank, Dihexa. For cycling logic across these compounds, Cycling Peptides: A Protocol Framework.